SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Follow-up) — Joe Louis

PatientJoe Louis
Date of birth1971-05-13
IdentifiersMRN HR-BX002-SYN; SSN (made up) 000-02-6639
Document date2026-09-21
AuthorDesmond Achterberg-Cole, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Ten-week review: remission, antipsychotic taper, cognition and the echocardiogram. [S]

History of Present Illness

Mr. Louis returns one week after his preventive visit. He has had no persecutory beliefs for about six weeks and sleeps six to seven hours. In the last week of August he was out of town for four days of paid appearances and missed two urine tests; the day after he came home, with an old acquaintance, he used cocaine on one day. He reported it himself at his next test, which was positive, and all tests since have been negative. He had no psychotic symptoms after that use. His stool test kit came back negative. His home readings average 128/80 mmHg. The echocardiogram was done this morning. [S]

ElementDetail
CocaineOne day of use three weeks ago, reported by him; none since
Urine testsTwo missed while away; one positive after the lapse; the rest negative
Psychotic symptomsNone for six weeks, including after the lapse
Home blood pressureAverage 128/80 mmHg
Stool testNegative

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy good
CardiovascularNegativeNo chest pain, palpitations or ankle swelling
NeurologicalNegativeNo memory lapses, restlessness or tremor
PsychiatricNegativeNo persecutory beliefs; disappointed by the lapse but steady; no thoughts of suicide or of harming anyone

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives withOne spray as needed for suspected overdose; repeat in 2 to 3 minutes if neededNasal route2026-07-13activeS
Aripiprazole 5 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-07-20 to 2026-09-21completedS
Aripiprazole 2 mg oral tablet, one tablet each morning for two weeks, then stopOne tablet each morning for two weeks, then stopOral route2026-09-21 to 2026-10-05completedS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-08-10activeS
Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestionTwo sprays in each nostril up to every 4 hours as neededNasal route2026-08-03 to 2026-08-08completedS
Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for sore throat or aches, no more than 3,000 mg a dayOne or two tablets every 6 hours as needed, no more than 3,000 mg a dayOral route2026-08-03 to 2026-08-08completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-21Body height187cmS
2026-09-21Body weight102.1kgS
2026-09-21Body mass index (BMI) [Ratio]29.2kg/m2S
2026-09-21Systolic blood pressure130mm[Hg]S
2026-09-21Diastolic blood pressure82mm[Hg]S
2026-09-21Heart rate74/minS
2026-09-21Respiratory rate16/minS
2026-09-21Body temperature36.6CelS
2026-09-21Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-21Left ventricular Ejection fraction60%52-72%NormalS
2026-09-21Total score [MoCA]27{score}S
2026-09-21Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Physical Exam

Vital signs recorded on 2026-09-21; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 130/82, pulse 74; weight 102.1 kg, BMI 29.2
CardiovascularRegular rhythm; no murmur; no ankle edema
NeurologicalNo tremor, rigidity or abnormal movements; no akathisia
PsychiatricCalm and engaged; no delusional content; MoCA 27

Problems

ProblemClinical statusVerificationCodeProvenance
Persecutory thoughts and poor sleep for about two months: a fixed belief that people are following him and plan to harm him, three to four hours of sleep a night, partial insight; cause under evaluationresolvedconfirmed R41.89S — Synthetic presenting problem anchored to his documented fears of a plot against his life; resolved into the diagnosis at the consultation. Not a claim about his real symptoms.
Cocaine use disorder, severe (seven of eleven DSM-5-TR criteria): intranasal cocaine most days for about a year, last use three days before intakeresolvedconfirmed F14.20S — Synthetic modern coding at intake; superseded at the consultation by the combined code once the psychotic disorder was diagnosed. Person-first language; not a claim about his real diagnosis.
Cocaine use disorder, severe, with cocaine-induced psychotic disorder (persecutory delusions during heavy use, persisting ten days after the last use, with no history of psychosis off cocaine, a normal examination and no evidence of a neurocognitive disorder); psychotic symptoms resolved within four weeks on aripiprazoleactiveconfirmed F14.250S — Synthetic modern diagnosis made at the consultation. Not a claim about his real diagnosis.
Raised blood pressure at intake (154/98 mmHg) three days after cocaine use, without a diagnosis of hypertension; home readings plannedresolvedconfirmed R03.0S — Synthetic presenting finding; resolved into a diagnosis of hypertension at four weeks.
Hypertension, stage 2, confirmed four weeks after the last cocaine use (clinic 146/92, home average 144/90 mmHg), with mild concentric left ventricular hypertrophy and a normal aortic root on echocardiography; treated with amlodipineactiveconfirmed I10S — Synthetic modern diagnosis made at the four-week visit.
Financial insecurity: years of tax debt from his time as a well-paid athlete, now settled, left him with no savings; irregular income from paid appearances; worry about money keeps him awakeactiveconfirmed Z59.86S — Synthetic social need anchored to his documented tax debt.
Acute viral upper respiratory infection (common cold) for three days; rapid tests negative for influenza and COVID-19; resolved within ten days without antibioticsresolvedconfirmed J06.9S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementCocaine use since the last visit (his own account), cravings and triggersEvery visitCompleted todayOne day of use about three weeks ago; none since
LaboratoryUrine drug tests in contingency management, with fentanyl, and prize draws for negative resultsTwice weekly for twelve weeks, then at visitsDeferredTwo tests were missed while he was away for four days in late August, and he used cocaine on one day after returning; the next test was positive and all later tests negative. No lasting harm: he reported the use himself, had no psychotic symptoms and stopped at once. Corrective action: a travel plan with testing at a partner clinic and phone therapy sessions
ExaminationPsychotic symptoms, insight and sleepEvery visitCompleted todayNo psychotic symptoms for six weeks, including after the lapse
Medication safetyAntipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS)Weight and akathisia at every visit while on treatment; AIMS at baseline and every six monthsCompleted todayWeight 102.1 kg, up 1.1 kg since starting; no akathisia or abnormal movements; taper to 2 mg today
LaboratoryFasting glucose or hemoglobin A1c and lipids on an antipsychoticBaseline, at four months, then yearlyUp to dateBaseline done; the four-month check will not be needed if aripiprazole stops as planned
ExaminationCognitive screen (MoCA)At baseline and again once he is well and off cocaineCompleted todayMoCA 27, normal, after ten weeks well
ExaminationBlood pressure in clinic and at homeEvery visit; home readings before diagnosis and after each changeCompleted todayClinic 130/82; home average 128/80 mmHg on amlodipine
ImagingEchocardiogram for stage 2 hypertension or left ventricular hypertrophyAt diagnosisCompleted todayEjection fraction 60%; mild concentric left ventricular hypertrophy; aortic root 3.6 cm and ascending aorta 3.5 cm
SurveySuicide and violence risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or of harming anyone after the lapse
Medication safetyNaloxone and fentanyl test strips on handEvery visitCompleted todayNaloxone at home; he used a test strip the day of the lapse
SurveyDepression (PHQ-9) and anxiety (GAD-7)At baseline and every four weeks while in treatmentCompleted todayPHQ-9 3, item 9 scored 0; PHQ-2 0 at the preventive visit
Self-managementCognitive behavioral therapyWeeklyCompleted todayEight of nine sessions attended; the missed one was during the trip
Self-managementFinances, social work and taxpayer servicesEvery visitCompleted todayTax clinic appointment kept; awaiting their review
Self-managementFamily involvement, only with his consentEvery visitCompleted todayNo family contact requested by him

Goal progress:

Guideline basis: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020); Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021); National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026)

Follow-up: Fifteen-week review in five weeks, after the taper. Contingency management to the end of twelve weeks; therapy weekly. Call the clinic or 988 if the fears or sleeplessness return. Next scheduled visit 2026-10-26: fifteen-week review off the antipsychotic: recovery, blood pressure and finances. [S]